All Posts: Lombardi Stories
-
Toretsky Named Inaugural Hyundai Hope on Wheels Endowed Chair in Pediatric Oncology
In honor of his dedication to pediatric cancer research, Jeffrey A. Toretsky, MD, professor of oncology at Georgetown University School of Medicine, was formally named the inaugural holder of the Hyundai Hope on Wheels Endowed Chair in Pediatric Oncology during an investiture celebration at Riggs Library.
Category: Lombardi Stories
-
Meet the 2025 BellRinger Fellows
Meet this year’s BellRinger Fellows, who worked alongside investigators at GeorgetownLombardi, gaining valuable experience and insight into how cancer research is conducted.
Category: Lombardi Stories
-
Celebrating a Milestone in Cancer Research
This month marks the 50th anniversary of the publication of a paper by now-Georgetown Lombardi member Marc E. Lippman, MD, MACP, FRCP, and his colleague Gail Bolan, MD, that showed for the first time that the hormone estrogen can drive the growth of breast cancer. It was a pivotal moment in cancer research that has led to life-extending and lifesaving treatments for the thousands of people who develop breast cancer each year.
Category: Lombardi Stories
-
Georgetown Faculty Share Research and Explore Collaborations on Global Cervical Cancer
In June 2025, the Global Cancer Collaborative, a joint initiative between the Georgetown University Global Health Institute and Georgetown Lombardi, hosted a seminar on cervical cancer. Three presenters from Georgetown, including Lombardi member Alejandra Hurtado de Mendoza, PhD, detailed their current work, and attendees from across the university were invited to discuss new opportunities for interdisciplinary collaboration.
Category: Lombardi Stories
-
Men’s Event Celebrates 25 Years of Advances in Cancer Research
At the 25th anniversary of the Men’s Event, benefiting Georgetown University’s Lombardi Comprehensive Cancer Center, attendees celebrated the developments that have improved the prognosis for those diagnosed with the most prevalent types of men’s cancers, including advances in immunotherapy, precision medicine and minimally invasive surgery.
Category: Lombardi Stories
-
Lombardi Gala Brings Together Friends, Supporters
Continuing a tradition spanning nearly four decades, more than 450 friends and supporters of Georgetown University’s Lombardi Comprehensive Cancer Center gathered for an evening of elegant fun and fundraising at the 37th annual Lombardi Gala.
Category: Lombardi Stories
-
Gift Strengthens Support for Parents with Cancer and Their Families
Georgetown Lombardi announces the establishment of a new initiative designed to provide information and support services to parents with cancer. Thanks to a substantial gift from Elizabeth’s Smile, a cancer support organization co-founded by Nancy Hungerford, Georgetown Lombardi will develop an Interventions for Managing Parenting and Cancer Team (IMPACT) and a signature program called Family Circle by Elizabeth’s Smile.
Category: Lombardi Stories
-
Georgetown Secures Highest Research Classification for the 30th Year
Georgetown has received the highest classification for its research and training, earning the Carnegie Classification of Institutions of Higher Education’s designation as an “R1” institution. The designation, awarded to U.S. universities with “very high research activity,” marks the 30th year Georgetown has achieved top-tier stature.
Category: Lombardi Stories
-
4th Annual Kovach Lecture Focuses on Survivorship
(January 16, 2025) — The Lombardi Comprehensive Cancer Center hosted the fourth-annual Edward M. Kovach Cura Personalis Endowed Lecture at Georgetown on Jan. 9, spotlighting one of Georgetown’s core
Category: Lombardi Stories
-
With a New ‘Map’ of Cells, Georgetown Cancer Researchers Chart a Course to More Effective Treatment
Faculty and students from Biomedical Graduate Education programs, the School of Medicine and Lombardi Comprehensive Cancer Center are developing a new technique that could revolutionize the way cancers are tracked and treated. Instead of invasive surgical biopsies or time-consuming scans, clinicians could use simple blood tests to determine where the cancer is and whether it is responding to treatment.
Category: Lombardi Stories